Efficacy of vonoprazan-based second-line Helicobacter pylori eradication therapy in patients for whom vonoprazan-based ﬁrst-line treatment failed

Gut. 2017 Apr;66(4):752-753. doi: 10.1136/gutjnl-2016-312028. Epub 2016 May 17.

Authors

Yasumi Katayama¹, Kouji Toyoda¹, Yuumi Kusano¹, Toshikuni Suda¹, Shogo Adachi^{1

2}, Itsuo Terauchi³, Shigeki Oka⁴, Morio Takahashi⁵, Masaya Tamano¹

Affiliations

¹ Department of Gastroenterology, Dokkyo Medical University Koshigaya Hospital, Koshigaya, Saitama Prefecture, Japan.
² Department of Gastroenterology, Uchida Hospital, Tokyo, Japan.
³ Department of Gastroenterology, Akiya Hospital, Satte, Saitama Prefecture, Japan.
⁴ Oka Clinic, Koshigaya, Saitama Prefecture, Japan.
⁵ Morio Clinic, Koshigaya, Saitama Prefecture, Japan.

PMID: 27196582
DOI: 10.1136/gutjnl-2016-312028

No abstract available

Keywords: ANTIBIOTIC THERAPY; HELICOBACTER PYLORI - TREATMENT; PROTON PUMP INHIBITION.

Publication types

Letter
Comment

MeSH terms

Amoxicillin
Anti-Bacterial Agents
Drug Therapy, Combination
Helicobacter Infections*
Helicobacter pylori*
Humans
Proton Pump Inhibitors
Treatment Outcome

Substances

Anti-Bacterial Agents
Proton Pump Inhibitors
Amoxicillin